Invenra has teamed up with Australian biomedical research and development center QIMR Berghofer Medical Research Institute to identify and characterize a panel of fully human therapeutic monoclonal antibodies against a novel…

Invenra announced last week that is has teamed up with UK-based biotech company Oxford BioTherapeutics (OBT) to identify and characterize a panel of fully human therapeutic monoclonal antibodies (mAbs) against…

Biotech company Invenra announced recently that it raised more than $2 million dollars from investors. According to Vice President Mark Kubik, the funds will be used primarily for working capital…